ZNF704
Zinc finger protein 704
Also known as: FLJ16218, Gig1, ZN704_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZNC4
- Gene
- ZNF704
- Ensembl
- ENSG00000164684
- Chromosome
- 8
- Canonical length
- 412 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
412 residues, UniProt reviewed canonical sequence.
>Q6ZNC4|ZNF704
1 MTFTFQSEDL KRDCGKKMSH QHVFSLAMEE DVKTADTKKA SRILDHEKEN TRSICLLEQK
61 RKVVSSNIDV PPARKSSEEL DMDKVTAAMV LTSLSTSPLV RSPPVRPNES LSGSWKEGGC
121 VPSSTSSSGY WSWSAPSDQS NPSTPSPPLS ADSFKPFRSP AQPDDGIDEA EASNLLFDEP
181 IPRKRKNSMK VMFKCLWKNC GKVLSTAAGI QKHIRTIHLG RVGDSDYSDG EEDFYYTEIK
241 LNTDSVADGL SSLAPVSPSQ SLASPPTFPI PDSSRTETPC AKTETKLMTP LSRSAPTTLY
301 LVHTDHAYQA TPPVTIPGSA KFTPNGSSFS ISWQSPPVTF TGIPVSPTHH PVGTGEQRQH
361 AHTVLSSPPR GTVSLRKPRG EGKKCRKVYG MENRDMWCTA CRWKKACQRF LDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF704 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 16 nTPM
- cervix: 14 nTPM
- ovary: 13 nTPM
- cerebellum: 13 nTPM
- endometrium: 12 nTPM
- pancreas: 12 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 471 nCPM
- renal connecting tubule cells: 467 nCPM
- bergmann glia: 428 nCPM
- mast cells: 424 nCPM
- oligodendrocytes: 422 nCPM
- distal convoluted tubule cells: 407 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 39 nTPM
- white matter: 30 nTPM
- basal ganglia: 23 nTPM
- midbrain: 22 nTPM
- thalamus: 21 nTPM
- medulla oblongata: 21 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.23
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.01
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF704 as an antibody target. Whether an autoantibody or antibody against ZNF704 could matter depends on whether native ZNF704 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF704 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF704 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...